2 weeks Ago
BY Tracy Brown Hamilton1 minute read WeightWatchers announced on Tuesday that it will offer a compounded version of Novo Nordisk's popular weight-loss drug Wegovy as part of its weight-management programs, a move that sent its shares soaring nearly 47%. The stock marked its highest close in over two months, as Reuters reported. In fact, shares of WW International were up another 55% in premarket trading on Wednesday.
The company's decision comes amid skyrocketing demand for weight-loss medications like Wegovy and Eli Lilly's Zepbound, both of which have shown the potential to help patients lose up to 20% of their body weight. Shortages of these drugs have opened the door for drug compounders to step in under U.S.
regulations, offering alternatives. WeightWatchers announced it will partner with a compounding company that adheres to strict Food and Drug Administration (FDA) manufacturing standards..
.. Tracy Brown Hamilton.
